Their results indicated that imaging omics characteristics based on multiple combined MRI sequences (enhanced T1WI, FLAIR, and DWI) could serve as a non-invasive auxiliary tool for predicting EGFR mutation status in lung adenocarcinoma. The gene discussed is EGFR; the disease is lung adenocarcinoma.